Skip to main content
. 2023 Dec 4;11:214. doi: 10.1186/s40337-023-00939-0

Table 2.

Demographics by probable eating disorder diagnosis or risk level

ARFID AN BN BED PD UFED At risk Low/no risk Significance
Agea, n (%) p < 0.01, V = 0.08
18–24 1348 (56.7%) 1410 (62.0%) 6548 (43.9%) 1739 (23.8%) 392 (45.2%) 6368 (42.0%) 1741 (36.3%) 892 (37.5%)
25–34 703 (29.6%) 425 (18.7%) 4534 (30.4%) 2383 (32.6%) 215 (24.8%) 4318 (28.5%) 1332 (27.7%) 642 (27.0%)
35–44 171 (7.2%) 212 (9.3%) 2054 (13.8%) 1518 (20.8%) 145 (16.7%) 2105 (13.9%) 761 (15.9%) 347 (14.6%)
45–54 66 (2.8%) 116 (5.1%) 1064 (7.1%) 903 (12.4%) 75 (8.6%) 1314 (8.7%) 515 (10.7%) 251 (10.6%)
55–64 45 (1.9%) 67 (2.9%) 521 (3.5%) 537 (7.4%) 30 (3.5%) 710 (4.7%) 291 (6.1%) 165 (6.9%)
65 +  45 (1.9%) 43 (1.9%) 190 (1.3%) 222 (3.1%) 11 (1.2%) 357 (2.4%) 161 (3.4%) 80 (3.4%)
Genderb, n (%) p < 0.01, V = 0.05
Female 1808 (76.0%) 2014 (88.6%) 12,894 (86.5%) 6494 (88.9%) 775 (89.3%) 12,551 (82.7%) 4149 (86.4%) 1808 (76.4%)
Male 349 (14.7%) 99 (4.4%) 1273 (8.5%) 548 (7.5%) 41 (4.7%) 1712 (11.3%) 413 (8.6%) 454 (19.2%)
Non-binary 147 (6.2%) 87 (3.8%) 502 (3.4%) 167 (2.3%) 36 (4.1%) 614 (4.0%) 149 (3.1%) 53 (2.2%)
Other 66 (2.8%) 57 (2.5%) 221 (1.5%) 81 (1.1%) 14 (1.6%) 260 (1.7%) 74 (1.5%) 50 (2.1%)
Racec, n (%) p < 0.01, V = 0.04
White 1793 (75.4%) 1794 (78.9%) 11,532 (77.3%) 6192 (84.8%) 700 (80.6%) 12,152 (80.1%) 3736 (77.8%) 1844 (78.5%)
Black 151 (6.3%) 49 (2.2%) 726 (4.9%) 242 (3.3%) 26 (3.0%) 682 (4.5%) 223 (4.6%) 128 (5.5%)
Asian 108 (4.5%) 141 (6.2%) 695 (4.7%) 188 (2.6%) 37 (4.3%) 626 (4.1%) 247 (5.1%) 123 (5.2%)
Multiracial 152 (6.4%) 139 (6.1%) 735 (4.9%) 287 3.9%) 46 (5.3%) 691 (4.6%) 221 (4.6%) 97 (4.1%)
Other 153 (6.5%) 105 (4.6%) 1105 (7.4%) 346 (4.8%) 55 (6.3%) 904 (6.0%) 311 (6.5%) 156 (6.6%)
Ethnicityd, n (%) p < 0.01, V = 0.04
Hispanic 326 (13.7%) 234 (10.3%) 2277 (15.3%) 769 (10.5%) 108 (12.4%) 1801 (11.9%) 605 (12.6%) 271 (11.5%)
Non-Hispanic 2039 (85.7%) 2009 (88.4%) 12,567 (84.3%) 6504 (89.1%) 757 (87.2%) 13,290 (87.6%) 4152 (86.5%) 2083 (88.5%)
Incomee, n (%) p < 0.01, V = 0.04
 < $20 k 487 (20.5%) 394 (17.3%) 2347 (15.7%) 764 (10.5%) 156 (18.0%) 2380 (15.7%) 624 (13.0%) 318 (13.9%)
$20 k-59,999 829 (34.8%) 640 (28.1%) 4557 (30.6%) 2066 (28.3%) 250 (28.8%) 4271 (28.2%) 1211 (25.2%) 554 (24.2%)
$60 k-99,999 486 (20.4%) 479 (21.1%) 3288 (22.1%) 1903 (26.0%) 189 (21.7%) 3427 (22.5%) 1086 (22.6%) 557 (24.3%)
$100 k-150 k +  499 (21.0%) 643 (28.2%) 4322 (29.0%) 2379 (32.6%) 249 (28.7%) 4599 (30.3%) 1674 (34.9%) 861 (37.6%)

Pairwise comparisons were conducted following significant Chi-square tests

aRespondents with possible ARFID were more likely to be aged 18–24 than all other diagnostic/risk categories except those with AN

bRespondents with possible ARFID were more likely to be male and less likely to be female than all other diagnostic/risk categories except those with low/no ED risk

cThey were less likely to be White, and more likely to be Black or African American than all other diagnostic/risk groups

dThey were also more likely to be Hispanic/Latino than all diagnostic/risk groups except those with BN

eThey were more likely to have lower household income (< $20,000 and $20,000–59,999) than all other diagnostic/risk categories